Due to the critical role of HGF/c-Met axis in angiogenesis and anti-tumor drug resistance in pathophysiological processes, this pathway has gradually become an attractive target for anti-tumor angiogenesis therapy. The gene discussed is HGF; the disease is neoplasm.